Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Esophagitis induced by combined radiation and adriamycin. [Mediastinum irradiated to doses between 500 and 2500 rad]

Journal Article · · Am. J. Roentgenol.; (United States)
With the increasing use of combined chemotherapy and radiotherapy in the treatment of certain types of malignancy, a clinically distinct type of esophagitis has been recognized as an undesirable side effect. It occurs with low doses (less than 2,000 rad) of mediastinal radiation in patients who simultaneously or sequentially receive either adriamycin or actinomycin D. Characteristic of this entity is recall: recurrent episodes of esophagitis with each course of chemotherapy. The radiographic findings are nonspecific, ranging from subtle alterations in motility to severe damage with irreversible stricture formation. The primary differential diagnostic considerations are infectious processes. The radiographic spectrum clinical aspects, and differential diagnoses in five patients are discussed.
Research Organization:
Harvard Medical School, Boston, MA
OSTI ID:
6370633
Journal Information:
Am. J. Roentgenol.; (United States), Journal Name: Am. J. Roentgenol.; (United States) Vol. 132:4; ISSN AJROA
Country of Publication:
United States
Language:
English